Payer GTM Strategy & Execution.
A PE-backed clinical data intelligence platform with three decades of provider-market dominance stood up its first payer go-to-market motion in five weeks: 25 priority targets, a systematized outreach engine, and a Pilot Support Program ready to catch the first signed pilots.
Company Profile
PE-backed clinical data intelligence platform approaching the end of PE’s hold period with heightened focus on growth metrics. Three decades selling into the provider market with 4,000+ active client relationships. A workflow-embedded risk adjustment product ready for the payer market. The commercial team had product-market fit on the provider side but had not run a payer go-to-market motion at scale.
The Challenge
The product was ready. The market was not the problem. The problem was that the payer market is wide, fragmented across lines of business, and the company had less experience selling into it than into providers, where the buying personas are much different.
The PE thesis required entering the payer segment at speed, and the commercial engine needed three things it did not yet have: a defensible target list it could put in front of the board, outreach materials with a defined value proposition tuned to payer buyers who carry different decision criteria than the provider buyers the team knew well, and a customer success motion ready to catch the first signed pilots without losing momentum at signature.
The client carried real differentiators into the engagement: data source modularity across EHRs and claims, three decades of provider-market dominance with 4,000+ active client relationships, and true in-workflow integration of their risk adjustment product. The engagement was about translating that asset base into a payer GTM value proposition and motion the team had not run before.
The 5-Week Engagement
3PS scoped a five-week engagement to stand up the payer go-to-market motion, from a defensible diagnostic through a working Sales-and-CS handoff.
Weeks 1–2: Diagnose
A top-down read of the payer market and a bottoms-up read of the existing client book ran in parallel through the Aequalis Payer Insights Platform, the analytical engine that powered both views and surfaced the targets neither read would have found alone.
The top-down view filtered the payer market to the lines of business where workflow-embedded risk adjustment creates measurable value. Medicare Advantage surfaced as the primary target. Select Medicaid managed care markets followed. Commercial and ACA were largely ruled out for this product cycle.
The bottoms-up view mapped every health system and provider organization in the active client base against payer asset ownership. Which systems operate a Provider Sponsored Health Plan. Which Provider Sponsored Health Plans hold MA or Medicaid contracts at full risk. Aequalis enriched both views with PSHP membership, LOB mix, HEDIS performance, acquisition history, and trajectory indicators across the last three to five years.
Account-level revenue sizing then translated member counts and risk-pool economics into addressable revenue per target. The sizing also factored in feasibility: public quality and risk-adjustment signals that suggested which PSHPs were most likely to mobilize for new technology, since willingness to buy was not the same across all. Buyer maps followed for each priority org: the economic buyer, the clinical champion, and the operational owner of risk adjustment workflows.
Weeks 3–4: Build
The build stood up the two motions the client did not yet have: a systematized outreach engine for payer buyers, and a Pilot Support Program so the Customer Success team could catch a signed contract clean.
The outreach engine was built for payer personas the Sales team had not engaged with historically. New scripts were required. The approach blended 3PS payer expertise with AI copy and sales messaging capabilities: email sequences, call scripts, talk tracks, objection responses, and one-pagers tuned by LOB and buyer role. Humans owned every external touch. AI sat behind the scenes as drafting support.
The Pilot Support Program was the operating wrapper for a signed pilot. A gap surfaced in the diagnostic: Customer Success had been engaged too late in the Sales cycle. By the time a contract was signed, the momentum and context built during the Sales motion had started to evaporate. The Pilot Support Program fixed this with a defined Sales-to-CS handoff moment, intake forms, training curriculum tuned to PSHP workflows, rollout reporting templates, and success criteria worked out before the first pilot landed.
Week 5: Operate Handoff
Sales motion handed to the SVP Sales and the BDRs. The Customer Success team activated behind Sales, ready for the first PSHP signature. Defined annual refresh scheduled with the Aequalis Payer Insights Platform so the priority list re-scores as PSHP membership, HEDIS posture, and acquisition activity move.
Results
Functional Areas Touched
The engagement created downstream impact across the commercial side of the business. The map below shows a typical clinical-data-platform operating structure. Highlighted nodes are where this engagement created downstream impact.